Company to Showcase its HOLO Portal™ Surgical Guidance System for the First Time at an Industry Event, Featuring Live, Hands-On Demos from Surgeons and Healthcare Professionals.
DEERFIELD, Ill., Sept. 08, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA), a global medical technology company focused on raising the standard of care by driving the evolution of digital health, today announced two upcoming industry events in which it will participate and present several of its latest technological innovations.
The Minimally Invasive Spine Surgery Society (“SMISS”) will host its annual forum from September 29 to October 1, 2022 at the Bellagio in Las Vegas, NV. This three-day event brings together the international community of spine surgeons, orthopedic surgeons and neurosurgeons in an open forum focused entirely on minimally invasive spine surgery. Surgalign will exhibit (Booth #301) several of its latest product innovations, including its Coflex® Interlaminar stabilization device, CoFix™ MIS posterior fusion system and CervAlign® Anterior Cervical Plate System, as well as its portfolio of biomaterials and TETRAfuse® 3D technology. The Society will also participate in the MISS Track Cadaveric Lab on September 29e and for the first time at an industry event, will showcase its HOLO Portal™ surgical guidance system with hands-on live demonstrations.
The North American Spine Society (“NASS”) will welcome its 37e Annual Meeting October 12-15, 2022 at the McCormick Place-West Building in Chicago, IL. Founded in 1985, NASS is a global, multidisciplinary medical organization for healthcare professionals who specialize in spine care and are dedicated to fostering the highest quality, ethical, values-based spine care. and evidence-based through education, research and advocacy. This four-day event will include educational courses, symposia, webinars and various educational programs to foster better patient outcomes in spine care and will include hands-on demonstrations from leading spine surgeons in the whole world. Surgalign will exhibit (Booth #4841) its Coflex interlaminar stabilization device, its CoFix Posterior MIS fusion system, its CervAlign anterior cervical plate system and many of its biomaterials products and TETRAfuse 3D technology. The company will also showcase its HOLO Portal surgical guidance system at its booth.
“We have made great strides over the past year in developing and bringing to market new and differentiated products for our customers that are designed to improve patient outcomes, and we look forward to introducing many of our innovations at SMISS and NASS in the coming weeks. said Terry Rich, President and CEO of Surgalign. “We are especially excited to launch the HOLO Portal system at industry events as we move forward with our go-to-market initiatives and expand our reach.”
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health to drive transformation in the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company develops technologies that physicians and other healthcare providers will turn to for what is truly possible for their patients. Surgalign is focused on developing solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets its products throughout the United States and in approximately 50 countries around the world through a growing network of leading independent distributors. Surgalign is headquartered in Deerfield, IL, with shopping, innovation and design centers in San Diego, California, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.
This press release contains forward-looking statements based on management’s current expectations, estimates and projections regarding our products, our company and our industry, the beliefs of our management and certain assumptions made by our management. Words such as “anticipate”, “expect”, “intend”, “anticipate”, “believe”, “seek”, “estimate” and other variations of these words and similar expressions are intended to identify these forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in our public filings with the United States Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the Company’s filings with the SEC may be obtained by contacting the Company or the SEC or by visiting Surgalign’s website at www.surgalign.com or the SEC’s website at www.sec.gov.